Ulinastatin is a multivalent Kunitz-type serine protease inhibitor derived from human urine, with potential protective, anti-fibrinolytic and anticoagulant activities. Upon administration, ulinastatin (or urinary trypsinogen inhibitor) inhibits the activities of a variety of enzymes, including trypsin, chymotrypsin, thrombin, kallikrein, plasmin, elastase, cathepsin, lipase, hyaluronidase, factors IXa, Xa, XIa, and XlIa, and polymorphonuclear leukocyte elastase. The directory classifies it as a commercial API with a biotechnology source/manufacturing origin. Other names for this substance include Mingin and Estotin. Its PubChem CID is 105102.
Ulinastatin
| CAS No | 80449-31-6 |
|---|---|
| Molecular Formula | C13H16O3 |
| Molecular Weight | 220.26 g/mol |
| Synonyms | 3-(furan-2-yl)-2,4-dioxaspiro[5.5]undec-9-ene |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Ulinastatin is a multivalent Kunitz-type serine protease inhibitor derived from human urine, with potential protective, anti-fibrinolytic and anticoagulant activities.
The listed CAS number is 80449-31-6.
The listed molecular formula is C13H16O3.
The listed molecular weight is 220.26 g/mol.
3-(furan-2-yl)-2,4-dioxaspiro[5.5]undec-9-ene.
The source lists Mingin and Estotin.